http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1245023

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 99
issn 1837-9664
issueIdentifier 1
pageRange 92-99
publicationName Journal of Cancer
startingPage 92
bibliographicCitation Meng DF, Sun R, Peng LX, Huang YS, Yang Q, Luo DH, Hu WH, Xie FY, Luo W, Zhao C, Guo L, Mai HQ, Chen MY, Xie P, Zheng LS, Yang JP, Mei Y, Qiang YY, Xu L, Li CZ, Huang BJ, Qian CN, Sun R. A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study. J Cancer. 2018;9(1):92–9. PMID: 29290773; PMCID: PMC5743715.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c3b408e176cf13e30ec683ade481eb1f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0572ba6837f7193a015fc0fadecf1d5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7022ef4c37dfafc34299b914b7f66c52
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2ac001c2ea793e94017180f1f4021d4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b68cd6a832af6edf531ec4bcab86665
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48ecf32c6dda24fa86ca7f91328d2c0e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_034446d7a3870dec532701ae9989a831
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96f80c63784065f08027397b453ba850
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8edf2e866622dbfdc74419022a98e624
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2676a0e68734cecffe9dd07565a326f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2a4a90c5a73dcfedaa7e8e60f39d02d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1eefc7db5f942623351b9cac33035e26
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_444f5881a09d0d87fa87a4f5bdf5fede
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee11c9ad888c2d80e57ad2fd80699bc5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4dcab16932570146a6d8e1e35bda1dae
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d34e61d66c8a4436ef0b54d80259e394
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01cbd8504f2b98c0258e62fc86e8fdcd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c540e65395b04db67599726e81c6994
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a541170fff8b8f81894cde6ecc643f63
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_196957d7fd845c272155d8b6e64bf194
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d6fce1c5230cf1bdd2080f24875b1c0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b12f2a05ac926d37548799e14c967225
date 2018
identifier https://pubmed.ncbi.nlm.nih.gov/PMC5743715
https://pubmed.ncbi.nlm.nih.gov/29290773
https://doi.org/10.7150/jca.21357
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37885
https://portal.issn.org/resource/ISSN/1837-9664
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603

Showing number of triples: 1 to 44 of 44.